NCT05562206View on ClinicalTrials.gov

CGMIS 48-hour Feasibility Study

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions
Type1diabetes
Interventions
DEVICE

CGMIS (Continuous Glucose Monitoring Infusion Set)

An integrated combination CGM/insulin infusion system

Trial Locations (1)

98057

RECRUITING

Rainier Clinical Research Center, Renton

Sponsors
All Listed Sponsors
lead

Pacific Diabetes Technologies

INDUSTRY